Infections after primary and revision total hip replacement caused by enterobacteria producing extended spectrum β-lactamases (ESBL): A case series

HIP International

Volumn 20, Issue 2, 2010, Pages 248-254

  Haenle, Maximilian ^a   Podbielski, Andreas ^a   Mittelmeier, Wolfram ^a   Bader, Rainer ^a   Gradinger, Reiner ^b   Gollwitzer, Hans ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arthroplasty; ESBL; Infection; Revision surgery; Total hip replacement

Indexed keywords

BETA LACTAMASE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; COTRIMOXAZOLE; MEROPENEM; MOXIFLOXACIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CASE REPORT; DEBRIDEMENT; DEVICE INFECTION; DEVICE REMOVAL; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; LUNG INFECTION; POSTOPERATIVE INFECTION; PROTEIN EXPRESSION; REOPERATION; TOTAL HIP PROSTHESIS; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; FATALITY; HIP ARTHROPLASTY; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PROSTHESES AND ORTHOSES; PROSTHESIS FAILURE; SURGICAL INFECTION;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FATAL OUTCOME; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS FAILURE; REOPERATION; SURGICAL WOUND INFECTION;

EID: 77955724799     PISSN: 11207000     EISSN: None     Source Type: Journal    
DOI: 10.1177/112070001002000217     Document Type: Article

References (41)

1. Malchau H, Herberts P, Eisler T, Garellick G, Söderman P. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am 2002; 84 (Suppl 2): 2-20. (Pubitemid 35168331)
2. Geipel U, Hermann M. Das infizierte Implantat. Teil 1: Bakteriologie. Orthopäde 2004; 33: 1411-28.
3. Ip D, Yam SK, Chen CK. Implications of the changing pattern of bacterial infections following total joint replacement. J Orthop Surg (Hong Kong) 2005; 13: 125-30.
4. Garvin KL, Hinrichs SH, Urban JA. Emerging antibiotic-resistant bacteria. Their treatment in total joint arthroplasty. Clin Orthop Relat Res 1999; 369: 110-23.
5. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-86.
6. Witte W, Mielke M. β-Laktamasen mit breitem Wirkungsspektrum. Grundlagen, Epidemiologie, Schlussfolgerungen für die Prävention. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2003; 46: 881-90.
7. Ambler RP. The structure of β-lactamases. Philos Trans R Soc Lond B Biol Sci 1980; 289: 321-31.
8. D'Antonio JA. Periprosthetic bone loss of the acetabulum. Classification and mangement. Orthop Clin North Am 1992; 23: 279-90.
9. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-9.
10. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005; 87: 1746-51.
11. Rokosz A, Sawicka-Grzelak A, Luczak M. [Metallo-beta-lactamase-producing gram-negative rods isolated from inpatients and outpatients, detected using Etest MBL]. Med Dosw Mikrobiol 2006; 58: 73-81.
12. Altoparlak U, Erol S, Akcay MN, Celebi F, Kadanali A. The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns 2004; 30: 660-4. (Pubitemid 39314511)
13. Singh NP, Goyal R, Manchanda V, Das S, Kaur I, Talwar V. Changing trends in bacteriology of burns in the burns unit, Delhi, India. Burns 2003; 29: 129-32. (Pubitemid 36279589)
14. Ramakrishnan MK, Sankar J, Venkatraman J, Ramesh J. Infections in burn patients - experience in a tertiary care hospital. Burns 2006; 32: 594-6. (Pubitemid 43914135)
15. Esposito S, Capuano A, Noviello S, et al. Modification of patients' endogenous bacterial flora during hospitalization in a large teaching hospital in Naples. J Chemother 2003; 15: 568-73. (Pubitemid 38241406)
16. Pinto Pereira LM, Phillips M, Ramlal H, Teemul K, Prabhakar P. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy. BMC Infect Dis 2004; 4: 59.
17. Maegele M, Gregor S, Steinhausen E, et al. The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects. Crit Care Med 2005; 33: 1136-40.
18. Bercion R, Gaudeuille A, Mapouka PA, Behounde T, Guetahoun Y. [Surgical site infection survey in the orthopaedic surgery department of the "Hopital communautaire de Bangui," Central African Republic]. Bull Soc Pathol Exot 2007; 100: 197-200.
19. Ribes J, Rapp RP. Why is the microbiology lab calling about an extended-spectrum beta-lactamase bacterium from a wound culture? Orthopedics 2005; 28: 1322-5.
20. Dhawan B, Mohanty S, Das BK, Kapil A. Bacteriology of orthopaedic wound infections in an Indian Tertiary Care Hospital. Correspondence. Indian J Med Res 2005; 121: 784-5.
21. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res 2006; 124: 95-8.
22. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643-54.
23. Gastmeier P. [Prevention of nosocomial infections]. Chirurg 2008; 79: 263-72.
24. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35 (Suppl 2): 65-164.
25. Reddy P, Malczynski M, Obias A, et al. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 2007; 45: 846-52.
26. Clinical and Laboratory Standards Institute. M7-A7, Methods for dilution antimicrobial suspectibility tests for bacteria that grow aerobically; approved standard. 7th edition. Wayne, PA: Clinical and Laboratory Standards Institute 2006.
27. Jacoby GA, Walsh KE, Walker VJ. Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing betalactamases in Escherichia coli and Klebsiella pneumoniae by disk tests. J Clin Microbiol 2006; 44: 1971-6.
28. Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003; 63: 353-65.
29. Geisel R, Schmitz FJ, Dettenkofer M. Multiresistente Erreger (MRSA und VRE) sowie andere nosokomiale Problemkeime. In: Daschner F, Dettenkofer M, Frank U, Scherer M, eds. Praktische Krankenhaushygiene und Umweltschutz. 3rd ed. Heidelberg: Springer Medizin Verlag, 2006: 174-87.
30. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007; 35 (Suppl 2): S165-93.
31. Müller M, Morawietz L, Hasart O, Strube P, Perka C, Tohtz S. Diagnosis of periprosthetic infection following total hip arthroplasty - evaluation of the diagnostic values of pre- and intraoperative parameters and the associated strategy to preoperatively select patients with a high probability of joint infection. J Orthop Surg Res 2008; 3: 31.
32. Mückley T, Hierholzer C, Diefenbeck M, Hofmann GO, Bühren V. [Treatment of MRSA infection in orthopedic surgery]. Chirurg 2004; 75: 269-75.
33. Walls RJ, Roche SJ, O'Rourke A, McCabe JP. Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement. J Bone Joint Surg Br 2008; 90: 292-8.
34. Volin SJ, Hinrichs SH, Garvin KL. Two-stage reimplantation of total joint infections: a comparison of resistant and non-resistant organisms. Clin Orthop Relat Res 2004; 427: 94-100.
35. Kirr R, Wiberg J, Hertlein H. [Clinical experience and results of using the V.A.C. instill therapy in infected hip- and knee prosthetics]. Zentralbl Chir 2006; 131 (Suppl 1): S79-82.
36. Lehner B, Bernd L. [V.A.C.-instill therapy in periprosthetic infection of hip and knee arthroplasty]. Zentralbl Chir 2006; 131 (Suppl 1): S160-4.
37. Lüdemann M, Haid S, Wülker N, Rudert M. [Results of vacuum sealing therapy in joint infections]. Z Orthop Ihre Grenzgeb 2006; 144: 602-8.
38. Paterson DL, Yu VL. Extended-spectrum beta-lactamases: a call for improved detection and control. Clin Infect Dis 1999; 29: 1419-22.
39. Hornberg C, Knoop D, Kipp F. [The importance of MRSA in patient care. Epidemiology, prevention and therapy]. Orthopäde 2006; 35: 1159-68.
40. Geiss HK. [Hygienic measures in orthopedics: "German" or "American"?]. Orthopäde 2002; 31: 1045-7.
41. Podbielski A. MRE-Multiresistente Gram-negative Erreger. IMIKRO Universität Rostock, Krankenhaushygiene 2006. Available at: http://www.imikro.uni-rostock.de/Doku/Hygiene/HMB/MRE.pdf.